Compare Mounjaro V Wegovy Doses Through Expert Assessment
Online Prescription Assessment for Mounjaro V Wegovy Doses
Getting an online prescription for either Mounjaro or Wegovy doses requires understanding how each medication works differently in your body. Wegovy (semaglutide) is a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist. This fundamental difference affects dosing schedules, with Wegovy following a structured 20-week escalation from 0.25mg to 2.4mg maintenance dose. Mounjaro uses a different escalation pattern, starting at 2.5mg and potentially reaching 15mg for optimal effect.
Our online prescription process evaluates your medical history, current BMI, and any contraindications to determine which medication and starting dose suits your circumstances. Licensed UK prescribers review every clinical assessment within 3 working days, or 24 hours with our express service. The assessment covers previous weight management attempts, current medications, and cardiovascular health status. Both Wegovy and Mounjaro are available from EverydayMeds through our GPhC-registered pharmacy (#9012878), and your prescriber can help determine which treatment pathway offers the most appropriate dosing schedule for your needs.
Pricing Comparison for Mounjaro V Wegovy Doses Online
Wegovy doses start at £79.99 for the 0.25mg starter pen, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout to reach these final prices, whilst returning customers use code DOSE25. Our bundle options provide convenient supply continuity, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio covering three escalation doses for £369.99.
Mounjaro pricing follows a different structure due to its distinct dose escalation schedule and higher maximum doses. When comparing Mounjaro v Wegovy doses through our online prescription service, consider the total treatment cost over your planned duration rather than individual pen prices. Both medications are prescription-only medicines requiring ongoing clinical supervision, which our licensed prescribers provide through regular review appointments. The Ultimate Stability Trio provides three months of 2.4mg Wegovy maintenance supply for £649.99, offering treatment continuity for established patients.
Clinical Evidence Supporting Mounjaro V Wegovy Doses
The STEP clinical trial programme demonstrated Wegovy's efficacy across different patient populations, with the landmark STEP 1 trial showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). STEP 2 evaluated Wegovy in patients with type 2 diabetes, showing sustained weight management benefits. These trials established the current dose escalation protocol now used in clinical practice.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, evaluating tirzepatide's dual receptor mechanism across various patient groups. Comparing Mounjaro v Wegovy doses requires understanding that different trial designs, populations, and endpoints make direct weight loss percentage comparisons inappropriate. Both medications demonstrated cardiovascular benefits in their respective trials, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events.
How Wegovy Doses Work in Weight Management
Wegovy's dose escalation mimics the natural GLP-1 hormone that regulates appetite and gastric emptying. Starting with 0.25mg allows your body to adapt gradually, reducing potential gastrointestinal side effects whilst building therapeutic effect. The 0.5mg and 1mg doses continue this escalation, with many patients experiencing appetite reduction and increased satiety after smaller meals. The 1.7mg dose provides additional therapeutic benefit for patients requiring stronger appetite control, whilst 2.4mg represents the current maintenance dose for optimal long-term weight management. Each dose increase occurs every 4 weeks, allowing physiological adaptation and minimising tolerance development.
Online Prescription Process for Both Medications
Our 3-minute clinical assessment covers your medical history, current weight management goals, and any contraindications to either medication. Licensed UK prescribers review your submission alongside current NICE guidelines and MHRA licensing requirements for both treatments. Standard prescription review takes 3 working days, whilst our express service provides prescriber feedback within 24 hours for urgent treatment needs. Once approved, both Mounjaro and Wegovy ship via next-day cold-chain delivery to maintain medication stability. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet regulatory standards before dispatch, with ongoing clinical support available throughout your treatment journey.
Storage Requirements for Mounjaro V Wegovy Doses
Wegovy requires refrigeration at 2-8°C before first use but tolerates up to 6 weeks at room temperature below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy more suitable for frequent travellers or those with variable schedules. Both medications use pre-filled injection pens with clear dosing windows, though Wegovy's FlexTouch pen system offers tactile click confirmation for each 0.25mg increment. The dose escalation schedule requires careful pen rotation, with used pens discarded after 8 weeks regardless of remaining medication. Proper storage maintains medication potency throughout the escalation phases, ensuring consistent therapeutic effect as doses increase.
Personalised Dose Selection Through Online Consultation
Choosing between Mounjaro v Wegovy doses depends on your individual medical profile, lifestyle factors, and treatment preferences. Our online prescription service evaluates cardiovascular risk factors, existing diabetes status, and previous weight management attempts to guide medication selection. Some patients benefit from Wegovy's established dose escalation protocol, whilst others may suit Mounjaro's dual receptor mechanism and different dosing approach.
The online consultation process includes detailed questioning about meal timing, appetite patterns, and social eating situations to optimise dose selection. Your assigned prescriber considers these lifestyle factors alongside clinical indicators when recommending starting doses and escalation schedules. Both medications require commitment to reduced-calorie diet and increased physical activity, which our clinical team discusses during the prescription review process.
Complete Your Mounjaro V Wegovy Dose Assessment Today
Start your comparison of Mounjaro v Wegovy doses through our streamlined online prescription service at EverydayMeds. New customers use code FIRST40 at checkout, whilst returning patients apply code DOSE25 to access our competitive pricing structure. Our licensed prescribers provide expert guidance on dose selection, escalation schedules, and ongoing monitoring requirements for both medications. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which prescription-only medicine best supports your weight management goals. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which treatment and dosing schedule aligns with your individual needs and circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
